Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS??? DEFICIT (Details Narrative)

v3.22.2.2
STOCKHOLDERS’ DEFICIT (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Oct. 22, 2021
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Short-Term Debt [Line Items]            
Preferred stock shares authorized   10,000,000   10,000,000   10,000,000
Preferred stock, par or stated value per share   $ 0.0001   $ 0.0001   $ 0.0001
Preferred stock shares issued   0   0   0
Preferred stock shares outstanding   0   0   0
Common stock shares authorized   1,000,000,000   1,000,000,000   1,000,000,000
Common stock par value   $ 0.0001   $ 0.0001   $ 0.0001
Common stock shares issued   37,295,813   37,295,813   37,295,813
Common stock shares outstanding   37,295,813   37,295,813   37,295,813
Convertible Promissory Note [Member]            
Short-Term Debt [Line Items]            
Debt maturity date, description October 20, 2021 to October 20, 2022          
Stock issued during period shares 450,000          
Number of securities called by warrants 450,000          
Proceeds from issuance of common stock $ 197,501          
Term of warrants 5 years          
Exercise price of warrants per share $ 1.00          
Other expenses   $ 49,781 $ 0 $ 147,720 $ 0